secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001370053-25-000055
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio shareholders approve amended equity plan, elect directors at 2025 annual meeting
--------------------------------------------------------------------------------

- Elected Rita Jain, John Orwin, and J. Anthony Ware as Class II directors for three-year terms with over 21M votes for each.
- Approved amendment to 2017 Equity Incentive Plan with 18.0M for, 6.4M against; increases share reserve to 13.5M shares.
- Ratified KPMG as independent auditor for FY2025 with 27.2M votes for, 17K against.
- Advisory say-on-pay passed with 17.8M for, 6.6M against; shareholders preferred one-year frequency for future votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000137005325000055/0001370053-25-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000137005325000055/anab-20250617.htm
  HTML page:      https://secwatch.observer/filing/0001370053-25-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer